Skip to main content
2026 CRT Conference Main banner

CRT 2026

Spotlight

Session:: Spotlight Session | Hot Topics in Catheter-Directed Treatments for Pulmonary Embolism

Panel Discussion | Hot Topics in Catheter-Directed Treatments for Pulmonary Embolism

Saturday, March 7, 2026
9:48 AM - 10:00 AM EST
Location: Spotlight Theater

    Moderator(s)

  • Vikas Aggarwal, MD, MPH

    Director of venous and pulmonary vascular interventions
    Henry Ford Health System
    Ann Arbor, Michigan, United States

    Disclosure(s): No financial relationships to disclose

  • Jay Giri, MD, MPH

    Interventional Cardiologist
    University of Pennsylvania Perelman School of Medicine
    Philadelphia, Pennsylvania, United States

    Disclosure(s): Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Inari Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)

  • Rachel Rosovsky, MD, MPH

    Associate Professor, Harvard Medical school
    Massachusetts General Hospital
    Boston, Massachusetts, United States

    Disclosure information not submitted.

    • Panel Discussant(s)

  • George Chrysant, MD

    Chief Medical Officer
    INTEGRIS Cardiovascular Physicians, LLC
    Oklahoma City, Oklahoma, United States

    Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Acarix: Chief Medical Advisor (Ongoing); philips,shockwave,penumbra: Consulting Fees (e.g., advisory boards) (Ongoing)

  • Amir Kaki, MD, FACC, FSCAI

    Director Mechanical Circulatory Support Director High-Risk Complex Coronary Interventions
    Henry Ford St John Hospital
    Birmingham, Michigan, United States

    Disclosure information not submitted.

  • Andrew SP Sharp, MD

    Senior Medical Director
    Boston Scientific
    Galway, Galway, Ireland

    Disclosure(s): Boston Scientific: Employee (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing)

Disclosure(s):
Vikas Aggarwal, MD, MPH: No financial relationships to disclose
Jay Giri, MD, MPH: Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Inari Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)
Riyaz Bashir, MD: Thrombolex: Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock Options [in privately held companies] (Ongoing), Stock-privately held company (Ongoing)
George Chrysant, MD: Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Acarix: Chief Medical Advisor (Ongoing); philips,shockwave,penumbra: Consulting Fees (e.g., advisory boards) (Ongoing)
Eric A. Secemsky, MD, MSc: Abbott, Asahi, BD, Boston Scientific, Conavi, Cook, Cordis, Endovascular Engineering, Evident Vascular, Gore, InfraRedx, Medtronic, Penumbra, Philips, RapidAI, Rampart IC, R3, Regeneron, Shockwave, Siemens, SoniVie, Teleflex, Terumo, Thrombolex, Vent: Consulting Fees (e.g., advisory boards) (Ongoing)
Andrew SP Sharp, MD: Boston Scientific: Employee (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing)